Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

179 Periodical Search Results

You searched for "hormone receptor" AND "positive" OR "ruled in" OR "positive for" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 179 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer
    Eriko Tokunaga, Akemi Kataoka, Yasue Kimura, Eiji Oki, Kojiro Mashino, Kojiro Nishida, Tadashi Koga, Masaru Morita, Yoshihiro Kakeji, Hideo Baba, Shinji Ohno, Yoshihiko Maehara
    European Journal of Cancer
    March 2006 (Vol. 42, Issue 5, Pages 629-635)
    Abstract | Full Text | Full-Text PDF (192 KB)

  1. Triple negative breast cancers: Clinical and prognostic implications
    S.J. Dawson, E. Provenzano, C. Caldas
    European Journal of Cancer
    September 2009 (Vol. 45Supplement 1, Pages 27-40)
    Abstract | Full Text | Full-Text PDF (137 KB)

  1. The choice of systemic adjuvant therapy in receptor-positive early breast cancer
    Silvia Dellapasqua, Monica Castiglione-Gertsch
    European Journal of Cancer
    February 2005 (Vol. 41, Issue 3, Pages 357-364)
    Abstract | Full Text | Full-Text PDF (135 KB)

  1. Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status
    J.M. Dixon, J. Jackson, M. Hills, L. Renshaw, D.A. Cameron, T.J. Anderson, W.R. Miller, M. Dowsett
    European Journal of Cancer
    December 2004 (Vol. 40, Issue 18, Pages 2742-2747)
    Abstract | Full Text | Full-Text PDF (257 KB)

  1. A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93 , 26 September 2007
    Manfred Kaufmann, Erika Graf, Walter Jonat, Wolfgang Eiermann, Sabine Vescia, Matthias Geberth, Bettina Conrad, Günther Gademann, Ute-Susann Albert, Sibylle Loibl, Gunter von Minckwitz, Martin Schumacher, for the German Adjuvant Breast Cancer Study Group (GABG)
    European Journal of Cancer
    November 2007 (Vol. 43, Issue 16, Pages 2351-2358)
    Abstract | Full Text | Full-Text PDF (241 KB)

  1. Endocrine treatment and prevention of breast and gynaecological cancers
    P. P. Neven, I. I. Vergote, J. J. Van Ginderachter, P. P. van Dam, W. W. Tjalma, C. C. De Rop, F. F. De Prins
    European Journal of Cancer
    September 2002 (Vol. 38Supplement 6, Pages 1-11)
    Full Text | Full-Text PDF (146 KB)

  1. An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole
    C. Rose, O. Vtoraya, A. Pluzanska, N. Davidson, M. Gershanovich, R. Thomas, S. Johnson, J.J. Caicedo, H. Gervasio, G. Manikhas, F. Ben Ayed, S. Burdette-Radoux, H.A. Chaudri-Ross, R. Lang
    European Journal of Cancer
    November 2003 (Vol. 39, Issue 16, Pages 2318-2327)
    Abstract | Full Text | Full-Text PDF (213 KB)

  1. Wine, liquor, beer and risk of breast cancer in a large population , 17 December 2008
    Yan Li, David Baer, Gary D. Friedman, Natalia Udaltsova, Veronica Shim, Arthur L. Klatsky
    European Journal of Cancer
    March 2009 (Vol. 45, Issue 5, Pages 843-850)
    Abstract | Full Text | Full-Text PDF (150 KB)

  1. Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients - a jungle? , 15 August 2007
    Laura Biganzoli, Sara Licitra, Wederson Claudino, Marta Pestrin, Angelo Di Leo
    European Journal of Cancer
    October 2007 (Vol. 43, Issue 15, Pages 2270-2278)
    Abstract | Full Text | Full-Text PDF (337 KB)

  1. In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance
    I Fichtner, M Becker, R Zeisig, A Sommer
    European Journal of Cancer
    April 2004 (Vol. 40, Issue 6, Pages 845-851)
    Abstract | Full Text | Full-Text PDF (376 KB)

  1. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
    M.-C Mathieu, R Rouzier, A Llombart-Cussac, L Sideris, S Koscielny, J.P Travagli, G Contesso, S Delaloge, M Spielmann
    European Journal of Cancer
    February 2004 (Vol. 40, Issue 3, Pages 342-351)
    Abstract | Full Text | Full-Text PDF (329 KB)

  1. Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen
    Jenny Bergqvist, Goran Elmberger, John Ohd, Barbro Linderholm, Judith Bjohle, Henrik Hellborg, Hans Nordgren, Anna-Lena Borg, Lambert Skoog, Jonas Bergh
    European Journal of Cancer
    May 2006 (Vol. 42, Issue 8, Pages 1104-1112)
    Abstract | Full Text | Full-Text PDF (471 KB)

  1. c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease
    A Jukkola, R Bloigu, Y Soini, E.-R Savolainen, K Holli, G Blanco
    European Journal of Cancer
    February 2001 (Vol. 37, Issue 3, Pages 347-354)
    Abstract | Full Text | Full-Text PDF (135 KB)

  1. Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?
    S. Pignata, B. Daniele, C. Gallo, R. De Vivo, S. Monfardini, F. Perrone
    European Journal of Cancer
    January 1998 (Vol. 34, Issue 1, Pages 25-32)
    Abstract | Full Text | Full-Text PDF (104 KB)

  1. Molecular analysis of hormone receptor positive (luminal) breast cancers – What have we learnt? , 06 November 2008
    Sherene Loi
    European Journal of Cancer
    December 2008 (Vol. 44, Issue 18, Pages 2813-2818)
    Abstract | Full Text | Full-Text PDF (125 KB)

  1. Prediction of response to primary chemotherapy for operable breast cancer
    M Colleoni, E Orvieto, F Nolé, L Orlando, I Minchella, G Viale, G Peruzzotti, C Robertson, C Noberasco, V Galimberti, V Sacchini, P Veronesi, S Zurrida, R Orecchia, A Goldhirsch
    European Journal of Cancer
    April 1999 (Vol. 35, Issue 4, Pages 574-579)
    Abstract | Full Text | Full-Text PDF (74 KB)

  1. Methylated genes as new cancer biomarkers , 12 January 2009
    M.J. Duffy, R. Napieralski, J.W.M. Martens, P.N. Span, F. Spyratos, F.C.G.J. Sweep, N. Brunner, J.A. Foekens, M. Schmitt, on behalf of the EORTC PathoBiology Group
    European Journal of Cancer
    February 2009 (Vol. 45, Issue 3, Pages 335-346)
    Abstract | Full Text | Full-Text PDF (194 KB)

  1. Predictive value of HER-2 and Topoisomerase IIα in response to primary doxorubicin in breast cancer
    Edurne Arriola, Abelardo Moreno, Mar Varela, Jose M. Serra, Catalina Falo, Enrique Benito, Agustin P. Escobedo
    European Journal of Cancer
    November 2006 (Vol. 42, Issue 17, Pages 2954-2960)
    Abstract | Full Text | Full-Text PDF (163 KB)

  1. Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen
    W.R. Miller, J.M. Dixon, L. Macfarlane, D. Cameron, T.J. Anderson
    European Journal of Cancer
    March 2003 (Vol. 39, Issue 4, Pages 462-468)
    Abstract | Full Text | Full-Text PDF (386 KB)

  1. The role of early expression of inducible nitric oxide synthase in human breast cancer
    Sibylle Loibl, Angela Buck, Cornelia Strank, Gunter von Minckwitz, Marc Roller, Hans-Peter Sinn, Valerie Schini-Kerth, Christine Solbach, Klaus Strebhardt, Manfred Kaufmann
    European Journal of Cancer
    January 2005 (Vol. 41, Issue 2, Pages 265-271)
    Abstract | Full Text | Full-Text PDF (390 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 179 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.